Rupert Bourne
Professor of Ophthalmology Anglia Ruskin University
- Cambridge
Rupert Bourne is a Consultant Ophthalmic Surgeon at Cambridge University Hospitals and Director of Cambridge Eye Research Centre.
Media
Social
Biography
He is the Chair of the National Institute for Health Research Ophthalmology Speciality Group, responsible for NHS research delivery. In his role as Coordinator of the Vision Loss Expert Group of the Global Burden of Disease Study, he has overseen the long-term research into worldwide prevalence rates of blindness and visual impairment, in partnership with the World Health Organization.
Areas of Expertise
Accomplishments
Best Paper Award
2000
Singapore National Eye Centre conference. (oral presentation). The Use of the Heidelberg Retinal Tomograph - II in a population-based glaucoma survey.
Pharmacia ARVO Travel Award
2003
Winner of Royal Society of Medicine; Ophthalmology section: best overall presentation
2003
Education
University of London
M.D.
Medicine
2005
University of London
M.B.B.S.
Surgery
1994
Affiliations
- The Royal College of Ophthalmologists
- The Association for Research in Vision and Ophthalmology (ARVO)
- World Glaucoma Association
- European Glaucoma Society
- European School for Advanced Studies in Ophthalmology
- Section Editor for Eye, the journal of The Royal College of Ophthalmologists
Media Appearances
Quarter of people with severe sight loss have unmet needs
News Medical Life Sciences online
2020-10-16
We found self-reported severe vision problems in Europe were more frequently observed in the elderly, women, smokers and in those reporting greater social isolation.
Hundreds of thousands in UK aren't getting eye care they need
Cambridge Network online
2020-10-16
Lead author, Professor Rupert Bourne of Anglia Ruskin University (ARU) (pictured) said: “We found self-reported severe vision problems in Europe were more frequently observed in the elderly, women, smokers and in those reporting greater social isolation.
https://medicalxpress.com/news/2020-10-sight-loss.html
Medical Xpress online
2020-10-08
Researchers led by Rupert Bourne, Professor of Ophthalmology at Anglia Ruskin University (ARU), examined more than 500 studies showing trends in prevalence of blindness and vision loss, allowing them to make forecasts about vision loss over the next three decades.
Half of vision impairment in first world is preventable
Science Daily online
2018-03-26
"Overcoming barriers to services which would address uncorrected refractive error could reduce the burden of vision impairment in high-income countries by around half. This is an important public health issue even in the wealthiest of countries and more research is required into better treatments, better implementation of the tools we already have, and ongoing surveillance of the problem.
Global blindness set to 'triple by 2050'
BBC online
2017-08-03
"Even mild visual impairment can significantly impact a person's life," said lead author Prof Rupert Bourne, from Anglia Ruskin University.
"For example, reducing their independence... as it often means people are barred from driving."
Articles
Developing a Patient-Reported Outcome and Experience Measure for Glaucoma
Investigative Ophthalmology & Visual Science2020
Glaucoma and ocular hypertension patients, undergoing all types of treatment were recruited in a multi-centre study encompassing 9 centres across the East of England and Moorfield’s Eye Hospital London. Glaucoma related clinical data was collected for all eligible participants who also completed a questionnaire comprising the new glaucoma POEM and a battery of pre-existing health, vision and experience related instruments. The POEM was then Rasch analysed to assess category function, measurement precision, dimensionality, targeting and differential item functioning.
Strengthening the integration of eye care into the health system: methodology for the development of the WHO package of eye care interventions
BMJ Open Ophthalmology2020
The development of the package will be conducted in four steps: (1) selection of eye conditions (for which interventions will be included in the package) based on epidemiological data on the causes of vision impairment and blindness, prevalence estimates of eye conditions and health facility data.
Global Prevalence of Blindness and Distance and Near Vision Impairment in 2020: progress towards the Vision 2020 targets and what the future holds.
Investigative Ophthalmology & Visual Science2020
A systematic review and meta-analysis was conducted of population-based datasets relevant to global VI and blindness from 1980. Hierarchical models were fitted to estimate- by age, country, and year- the 2020 prevalence of (1) mild VI (presenting visual acuity worse than 6/12 to 6/18 inclusive), moderate to severe VI (MSVI; presenting visual acuity worse than 6/18 to 3/60 inclusive), and blindness (presenting visual acuity worse than 3/60); and (2) functional presbyopia (defined as presenting near vision worse than N6 or N8 at 40cm where best-corrected distance visual acuity was better than 6/12). Ninety-five percent uncertainty intervals (UI) were calculated.
Estimating the global cost of vision impairment and its major causes: protocol for a systematic review
BMJ open2020
Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic review of the literature is needed. Here we outline the protocol for a systematic review to describe and summarise the costs associated with VI and its major causes.
Self‐reported visual difficulties in Europe and related factors: a European population‐based cross‐sectional survey
Acta Ophthalmologica2020
In this context, we investigated self‐reported vision problems through European Health Interview Survey 2, a cross‐sectional European population survey based on a standardized questionnaire including 147 medical, demographic and socioeconomic variables applied to non‐institutionalized individuals aged 15 years or more in 28 European countries, in addition to Iceland and Norway.
